Dr. Kizmika Corbett of the NIAID explains the mechanics of the mRNA vaccine developed in collaboration with Moderna, which uses genetic material to encode the coronavirus spike protein. The NIAID reportedly owns a significant portion of the patents for this technology, which is being fast-tracked through the regulatory process. The delivery mechanism is described as a "Trojan horse" that recodes cells to produce an immune response.